Showing results (131-140 of 258) with videos related to
Sort By:
Pageof 26
Journal of Clinical Epidemiology|August 6, 2025
Inconsistency in publishers' responses to integrity concerns about published research. Evidence and suggested improvementsAndrew Grey, Alison Avenell, Alan Gaby, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 21, 2016
Conflicts of interest and expertise of independent commenters in news stories about medical researchMichael T M Wang, Andrew Grey, Mark J BollandEuropean Journal of Human Genetics : EJHG|May 10, 2021
Deletion of the last two exons of FGF10 in a family with LADD syndrome and pulmonary acinar hypoplasiaEmma M Wade, Padmini Parthasarathy, Jingyi Mi, et al.JBMR Plus|April 17, 2023
LRP6 High Bone Mass Characterized in Two Generations Harboring a Unique Mutation of Low-Density Lipoprotein Receptor-Related Protein 6Michael P Whyte, Steven Mumm, Jonathan C Baker, et al.Molecular and Cellular Endocrinology|May 3, 2006
Lactoferrin potently inhibits osteoblast apoptosis, via an LRP1-independent pathwayAndrew Grey, Qing Zhu, Maureen Watson, et al.Journal of Clinical Epidemiology|March 13, 2019
Rounding, but not randomization method, non-normality, or correlation, affected baseline P-value distributions in randomized trialsMark J Bolland, Greg D Gamble, Alison Avenell, et al.Journal of Clinical Epidemiology|May 17, 2021
Identical summary statistics were uncommon in randomized trials and cohort studiesMark J Bolland, Greg D Gamble, Alison Avenell, et al.Neurology|December 7, 2016
Systematic review and statistical analysis of the integrity of 33 randomized controlled trialsMark J Bolland, Alison Avenell, Greg D Gamble, et al.Endocrinology|September 10, 2003
Parallel phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways subserve the mitogenic and antiapoptotic actions of insulin-like growth factor I in osteoblastic cellsAndrew Grey, Qi Chen, Xin Xu, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 28, 2006
Peak bone mass after exposure to antenatal betamethasone and prematurity: follow-up of a randomized controlled trialStuart R Dalziel, Sheryl Fenwick, Tim Cundy, et al.Pageof 26